导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -6.99% | 764/1050 |
| 近一周 | -2.27% | 517/1104 |
| 近一月 | -1.10% | 156/1102 |
| 近一季 | -2.07% | 331/1092 |
| 近半年 | -6.39% | 666/1070 |
| 近一年 | -10.27% | 746/1018 |
| 近两年 | 37.46% | 615/926 |
| 近三年 | 30.37% | 391/834 |
| 成立以来 | 18.42% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-4.77% 797/1070 |
-7.49% 854/1101 |
- - |
- - |
| 2025 | 26.02% 566/1065 |
11.75% 109/1014 |
4.20% 347/1038 |
13.93% 767/1050 |
-5.01% 708/1065 |
| 2024 | 18.24% 113/1011 |
-1.36% 393/960 |
6.58% 64/983 |
13.31% 359/991 |
-0.73% 365/1011 |
| 2023 | -8.81% 292/952 |
0.65% 598/880 |
-1.11% 245/895 |
-5.54% 350/915 |
-3.01% 332/952 |
| 2022 | -1.88% 25/867 |
-4.87% 33/773 |
3.68% 597/806 |
-11.32% 322/845 |
12.18% 52/867 |
| 2021 | -9.62% 483/740 |
6.97% 31/580 |
0.76% 537/659 |
-10.05% 507/704 |
-6.78% 622/740 |
| 2020 | -2.67% 404/554 |
-12.36% 395/419 |
5.20% 414/466 |
-1.32% 433/517 |
6.99% 405/554 |
| 2019 | - - |
- - |
- - |
-5.26% 373/390 |
7.02% 275/410 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 景顺长城量化港股通股票A VS. 东吴新产业精选股票A(580008) |